Neiman Nix v. ESPN, Inc.

CourtCourt of Appeals for the Eleventh Circuit
DecidedMay 15, 2019
Docket18-14107
StatusUnpublished

This text of Neiman Nix v. ESPN, Inc. (Neiman Nix v. ESPN, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Neiman Nix v. ESPN, Inc., (11th Cir. 2019).

Opinion

[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT ________________________

No. 18-14107 Non-Argument Calendar ________________________

D.C. Docket No. 1:18-cv-22208-UU

NEIMAN NIX, DNA SPORTS PERFORMANCE LAB, INC.,

Plaintiffs - Appellants,

versus

ESPN, INC., THE ASSOCIATED PRESS, INC., USA TODAY,

Defendants - Appellees. ________________________

Appeal from the United States District Court for the Southern District of Florida ________________________ (May 15, 2019)

Before WILSON, MARTIN, and NEWSOM, Circuit Judges.

PER CURIAM:

This appeal arises out of a defamation action brought by Neiman Nix and

DNA (collectively, Appellants) against three media companies (collectively, Appellees) who published or republished a news article reporting on a lawsuit that

Nix filed against the MLB. The Appellees filed a motion to dismiss and asserted

several defenses. The district court applied New York law and dismissed the case

with prejudice. Appellants now appeal, arguing that the court erred in (1) deciding

to apply New York law, (2) determining that the fair report privilege and wire

service defenses warranted dismissal, and (3) concluding that the statements at

issue in the articles were true and did not have a defamatory implication. We

disagree with Appellants and affirm.

I.

In 2012, Nix opened a sports training center, DNA Sports Performance Lab,

Inc., in Florida. In addition to providing training services, DNA sells health

supplements, including a supplement derived from elk antler tissue that contains a

naturally occurring compound called IGF-1. DNA claims that the supplement has

many health benefits that improve athletic performance.

In 2013, the MLB launched an investigation into the illegal sale of

performance enhancing drugs to MLB players. The investigation targeted clinics

in Florida, including DNA. Nix filed a tortious interference suit against the MLB

in the Southern District of New York for harm to his reputation resulting from the

investigation. On the same day, the Associated Press (AP) published a news article

about Nix’s lawsuit against the MLB. ESPN and USA Today then republished the

2 reported information in their own articles. Each article contained the following

statement about Nix’s suit against the MLB: “The suit admits Nix and his company

used bioidentical insulin like growth factor (IGF-1), which is derived from elk

antlers and is on baseball’s list of banned substances.”1

Twenty months later, Appellants sued all three media companies in Florida

state court, seeking injunctive relief via removal or retraction of the articles and

damages for defamation and intentional infliction of emotional distress. Appellees

successfully removed the case to federal district court. Appellants alleged that the

statement about Nix’s ongoing suit against the MLB was incorrect and falsely

suggested that he sold banned substances to MLB players. Furthermore,

Appellants contended that the statement did not distinguish between natural and

synthetic forms of IGF-1, and thus wrongly implied that Appellants sold illegal

drugs, or legal drugs in an illegal manner.

Appellees moved to dismiss the complaint, and the district court granted

dismissal with prejudice. The district court applied New York law, determining

that (1) Appellants’ defamation claim was barred by New York’s one year statute

of limitations, (2) the Appellees’ statements fell within New York’s absolute fair

report privilege, (3) ESPN and USA could successfully apply a wire service

1 The MLB Prohibited Substances List includes “Insulin-like Growth Factor (IGF-1), including all isomers of IGF-1 sometimes referred to as Mechano Growth Factors.” The description does not include the source of the substance or limit the prohibition to synthetic IGF-1. 3 defense, and (4) Appellees’ statements were true and thus not defamatory.

Appellants now appeal, asserting that the district court wrongly applied New York

law in dismissing this case. Appellants further assert that the district court erred in

determining that the fair report privilege and wire service defenses warranted

dismissal of its defamation claims. Finally, Appellants argue that the district court

erred in determining that the statements at issue were true and could not plausibly

be interpreted to have a defamatory implication.

II.

We review the grant of a motion to dismiss de novo, “accepting the

allegations in the complaint as true and construing them in the light most favorable

to the plaintiff.” Miljkovic v. Shafritz & Dinkin, P.A., 791 F.3d 1291, 1296–97

(11th Cir. 2015) (quoting Hill v. White, 321 F.3d 1334, 1335 (11th Cir. 2003) (per

curiam)). We review a choice of law determination de novo and review the factual

findings underpinning that determination for clear error. Grupo Televisa, S.A. v.

Telemundo Commc’ns Grp., Inc., 485 F.3d 1233, 1239 (11th Cir. 2007).

“A federal court sitting in diversity will apply the conflict-of-laws rules of

the forum state” based on the particular legal issues in the case. Id. at 1240. When

faced with a conflict of laws in a torts case, Florida courts apply the “most

significant relationship” test outlined in the Restatement (Second) of Conflict of

Laws § 145. Id. The test lists four factors that courts must consider with respect to

4 each claim: (1) the place where the injury occurred; (2) the place where the

conduct causing the injury occurred; (3) the domicile, residence, nationality, place

of incorporation, and place of business of the parties; and (4) the place where the

relationship, if any, between the parties is centered. Id. “These factors are

considered according to their relative importance with respect to the particular

issue.” Michel v. NYP Holdings, Inc., 816 F.3d 686, 694 (11th Cir. 2016) (internal

quotation marks omitted). If the court cannot draw a conclusion based on these

four factors, it may then consider the seven factors outlined in the Restatement

(Second) of Conflict of Laws § 6. 2 Grupo Televisa, 485 F.3d at 1240. The seven

factors are not exclusive and the court may give different weight to particular

factors, or consider other factors in deciding a question of choice of law.

Restatement (Second) of Conflict of Laws § 6 (1971).

The Restatement (Second) of Conflict of Laws § 150 also states that when

defamatory information is published in more than one state, the “state of most

significant relationship” will usually be the state where the plaintiff was domiciled

or had its principal place of business at the time. This is premised on the notion

that the plaintiff will usually suffer greatest injury—by reason of loss of

reputation—in the state of domicile or principal place of business.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Masson v. New Yorker Magazine, Inc.
501 U.S. 496 (Supreme Court, 1991)
Lonnie J. Hill v. Thomas E. White, Secretary of the Army
321 F.3d 1334 (Eleventh Circuit, 2003)
Zerman v. Sullivan & Cromwell
677 F. Supp. 1316 (S.D. New York, 1988)
Woodard v. Sunbeam Television Corp.
616 So. 2d 501 (District Court of Appeal of Florida, 1993)
Miami Herald Pub. Co. v. Ane
458 So. 2d 239 (Supreme Court of Florida, 1984)
Firth v. State of NY
775 N.E.2d 463 (New York Court of Appeals, 2002)
Nedzad Miljkovic v. Shafritz and Dinkin, P.A.
791 F.3d 1291 (Eleventh Circuit, 2015)
Prakazrel Michel v. NYP Holdings, Inc.
816 F.3d 686 (Eleventh Circuit, 2016)
Layne v. Tribune Co.
146 So. 234 (Supreme Court of Florida, 1933)
Adelson v. Harris
876 F.3d 413 (Second Circuit, 2017)
James L. Turner v. Theodore v. Wells, Jr.
879 F.3d 1254 (Eleventh Circuit, 2018)
Cholowsky v. Civiletti
69 A.D.3d 110 (Appellate Division of the Supreme Court of New York, 2009)
D'Annunzio v. Ayken, Inc.
876 F. Supp. 2d 211 (E.D. New York, 2012)
Aguirre v. Best Care Agency, Inc.
961 F. Supp. 2d 427 (E.D. New York, 2013)
Adelson v. Harris
973 F. Supp. 2d 467 (S.D. New York, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Neiman Nix v. ESPN, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/neiman-nix-v-espn-inc-ca11-2019.